ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 411 filers reported holding ENCOMPASS HEALTH CORP in Q4 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $396,379 | -0.8% | 5,902 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $399,626 | -16.2% | 5,902 | -33.0% | 0.01% | -11.1% |
Q1 2023 | $476,838 | +19.0% | 8,814 | +31.5% | 0.01% | +12.5% |
Q4 2022 | $400,788 | +89.1% | 6,701 | +139.2% | 0.01% | +166.7% |
Q3 2021 | $212,000 | -74.8% | 2,802 | -78.3% | 0.00% | -70.0% |
Q3 2020 | $841,000 | -97.4% | 12,925 | -97.5% | 0.01% | -97.3% |
Q2 2020 | $31,938,000 | -16.1% | 515,678 | -13.3% | 0.38% | -25.7% |
Q1 2020 | $38,071,000 | -10.7% | 594,556 | -3.4% | 0.51% | +16.1% |
Q4 2019 | $42,645,000 | +0.4% | 615,609 | -8.3% | 0.44% | +0.7% |
Q3 2019 | $42,473,000 | +1.6% | 671,157 | +1.7% | 0.43% | -0.9% |
Q2 2019 | $41,820,000 | -4.1% | 660,012 | -11.6% | 0.44% | -7.4% |
Q1 2019 | $43,608,000 | +11.1% | 746,699 | +17.4% | 0.47% | -8.9% |
Q4 2018 | $39,254,000 | -17.7% | 636,196 | +4.0% | 0.52% | -7.2% |
Q3 2018 | $47,684,000 | +307.7% | 611,707 | +254.2% | 0.56% | +287.5% |
Q2 2018 | $11,697,000 | +76.6% | 172,714 | +49.1% | 0.14% | +69.4% |
Q1 2018 | $6,623,000 | – | 115,841 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
RK Capital | 179,800 | $13,492,000 | 2.55% |
Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |